Funding will go toward biologic research for orthopedic diseases, with a special focus on platelet-rich plasma and growth factor injections for rotator cuff tears and knee osteoarthritis.
Research evaluating the effect of tobacco, vaping and marijuana use on postoperative outcomes for total joint replacement and the effectiveness of antibiotic bone cement for prevention of periprosthetic joint infections will also be prioritized.
AAOS made the first investment to kickstart the fund.
More articles on orthopedics:
Geoff Martha, Kevin Lobo & more: 5 CEOs to know in the spine industry
Wright Medical inches toward sale, makes pay cuts due to pandemic: 5 updates
How COVID-19 has affected Medtronic, Stryker, Johnson & Johnson’s shares over the last month
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
